Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 6 Colonic Neoplasms 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Rectal Neoplasms 1 Peritoneal Neoplasms 1 Pancreatitis, Acute Necrotizing 1 Pancreatic Fistula 1 Pancreatic Cyst 1 Neoplasm Metastasis 1 Melanoma 1 Malignant Female Reproductive System Neoplasm 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Krukenberg Tumor 1 Hyperthermia 1 Fallopian Tube Neoplasms 1 Eye Neoplasms 1 Endometrial Neoplasms 1 Complex Ovarian Cyst 1 Colorectal Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Burkitt Lymphoma 1 Anastomotic Leak 1 Abdominal Injuries 1 Abdominal Abscess 1

Interventions

Paclitaxel 16 Carboplatin 14 Cisplatin 12 Oxaliplatin 9 Hyperthermic Intraperitoneal Chemotherapy 9 Cytoreduction Surgical Procedures 9 Fluorouracil 7 Bevacizumab 7 Doxorubicin 5 Leucovorin 4 Gemcitabine 4 catumaxomab 3 Docetaxel 3 Albumin-Bound Paclitaxel 3 130-nm albumin-bound paclitaxel 3 nintedanib 2 liposomal doxorubicin 2 epothilone B 2 Surgical Procedures, Operative 2 Palliative Care 2 Mitomycin 2 Laparoscopy 2 Interviews as Topic 2 Drug Therapy 2 Blood Specimen Collection 2 veliparib 1 tremelimumab 1 talimogene laherparepvec 1 strattice 1 sodium thiosulfate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Peritoneal Neoplasms × Laparotomy × Clear all

NCT01226394 2026-04-06

ProphyloCHIP

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed

Krukenberg Tumor, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡